Literature DB >> 3030346

Substances affecting the infection and replication of human immunodeficiency virus (HIV).

N Yamamoto, S Harada, H Nakashima.   

Abstract

The effects of various compounds were studied quantitatively on the growth of human immunodeficiency virus (HIV). For this we used a human T-cell leukemia virus type I carrying cell line, MT-4 which is most permissive for HIV infection. The results are summarized as follows: 1) Prostaglandin E2 and 12-0-tetradecanoylphorbol-13-acetate enhanced the production of HIV significantly in MT-4 cells as well as a continuous HIV producer Molt-4/HTLV-III cells. 2) Interferon gamma, retinoic acid and 3'-azido-3'-deoxythymidine inhibited the replication of HIV at the concentrations which were not cytotoxic. Mechanism of action of these compounds and its clinical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3030346

Source DB:  PubMed          Journal:  AIDS Res        ISSN: 0737-6006


  4 in total

1.  Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication.

Authors:  M Hughes-Fulford; M S McGrath; D Hanks; S Erickson; L Pulliam
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 2.  Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.

Authors:  Jonathan Bertin; Corinne Barat; Sylvie Méthot; Michel J Tremblay
Journal:  Retrovirology       Date:  2012-01-11       Impact factor: 4.602

3.  Feline calicivirus- and murine norovirus-induced COX-2/PGE2 signaling pathway has proviral effects.

Authors:  Mia Madel Alfajaro; Eun-Hyo Cho; Jun-Gyu Park; Ji-Yun Kim; Mahmoud Soliman; Yeong-Bin Baek; Mun-Il Kang; Sang-Ik Park; Kyoung-Oh Cho
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

Review 4.  Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract.

Authors:  Anthonio O Adefuye; Henry A Adeola; Kurt J Sales; Arieh A Katz
Journal:  J Immunol Res       Date:  2016-07-03       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.